More on compulsory registration of clinical trials: GSK has created useful register

BMJ

Volumn 330, Issue 7489, 2005, Pages 479-480

  Krall, Ronald ^a   Rockhold, Frank ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; INTERNATIONAL COOPERATION; LETTER; MEDICAL INFORMATICS; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL PROFESSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTRATION;

CLINICAL TRIALS; REGISTRIES;

EID: 14644435706     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.330.7489.479-b     Document Type: Letter

References (3)

1. Abbasi K. Compulsory registration of clinical trials. BMJ 2004; 329: 637–8 (18 September).
2. Correspondence. Compulsory registration of clinical trials. BMJ 2004; 329: 1043–4. (30 October.)
3. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004; 292: 1363.